2593 related articles for article (PubMed ID: 11419022)
1. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
2. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
Steiniche T
APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
[TBL] [Abstract][Full Text] [Related]
3. Primary hyperparathyroidism and the skeleton.
Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
Seeman E
Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.
Steiniche T; Christiansen P; Vesterby A; Ullerup R; Hessov I; Mosekilde LE; Melsen F
Bone; 2000 May; 26(5):535-43. PubMed ID: 10773596
[TBL] [Abstract][Full Text] [Related]
6. Primary hyperparathyroidism: lessons from bone histomorphometry.
Eriksen EF
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N95-7. PubMed ID: 12412784
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.
Huffer WE
Lab Invest; 1988 Oct; 59(4):418-42. PubMed ID: 3050272
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
10. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
Compston JE
Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
[TBL] [Abstract][Full Text] [Related]
11. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
Fox J; Miller MA; Recker RR; Turner CH; Smith SY
Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
[TBL] [Abstract][Full Text] [Related]
12. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
Boyce RW; Paddock CL; Franks AF; Jankowsky ML; Eriksen EF
J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
[TBL] [Abstract][Full Text] [Related]
13. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
[TBL] [Abstract][Full Text] [Related]
14. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
15. Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism.
Yajima A; Inaba M; Tominaga Y; Ito A
Am J Kidney Dis; 2007 Mar; 49(3):440-51. PubMed ID: 17336706
[TBL] [Abstract][Full Text] [Related]
16. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
[TBL] [Abstract][Full Text] [Related]
17. The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects.
Zerwekh JE; Ruml LA; Gottschalk F; Pak CY
J Bone Miner Res; 1998 Oct; 13(10):1594-601. PubMed ID: 9783548
[TBL] [Abstract][Full Text] [Related]
18. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism.
Reppe S; Stilgren L; Olstad OK; Brixen K; Nissen-Meyer LS; Gautvik KM; Abrahamsen B
Bone; 2006 Jul; 39(1):189-98. PubMed ID: 16516570
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
